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Background: A number of acute respiratory infections out-
breaks such as the 2009 inﬂuenza A (H1N1) and the Middle East
respiratory syndrome coronavirus (MERS-CoV) have emerged and
presented a considerable global public health threat. Epidemio-
logic evidence suggest that diabetic subjects are more susceptible
to these conditions. However, the global inﬂuence of diabetes to
the severity of H1N1 and MERS-CoV is yet to be evaluated.
Objective: The aim of this study was to carry out a systematic
review and meta-analysis documenting the prevalence of diabetes
in sever H1N1 and MERS-CoV to enable estimating its contribution
to the severity of these conditions.
Methods & Materials: A search strategy was developed for
online databases (PubMed, Ovid MEDLINE, Embase and Embase
Classic) using H1N1, MERS-CoV and DIABETES as search terms.
Reportsdocumenting theprevalenceofdiabetes in theseconditions
were identiﬁed. Meta-analysis for the proportions of diabetes in
sever conditions (95% conﬁdence intervals, CI) was carried out (29
H1N1 studies, n=92,948 subjects and 9 MERS-CoV studies, n=308).
Weighted averages of the extracted information and subgroup
analysis (by region) were carried out.
Results: Average age of H1N1 patients (38.0±9.2 yrs) was
lower than that MERS-CoV patients (54.9±10.1 yrs, p<0.05). The
prevalence rates of clinical symptoms such as pyrexia, dyspnea,
pharyngitis and pertussis were comparable between the two con-
ditions. Compared to MERS-CoV patients, H1N1 subjects exhibited
3-fold lower prevalence of cardiovascular diseases and 2- and 4-
foldhigherobesityand immunosuppression rates, respectively. The
prevalenceof diabetes in severH1N1was14.6% (95%CI: 12.3-17.0%;
p<0.001), a 3.7-fold lower than in MERS-CoV (54.4%; 95%CI: 29.4-
79.5; p<0.001). The contribution of diabetes to the severity of H1N1
from Asia (18%) and North America (20%) was 2-fold higher than
that from South America (9.8%) and Europe (10%).
Conclusion: The effect of diabetes is 4-fold higher in MERS-CoV
than in H1N1 and may play a signiﬁcant role in the susceptibly to
these conditions and vulnerability to their ensuing sever compli-
cations. The high prevalence of diabetes in H1N1 in North America
and Asia may reﬂect its elevated prevalence in these regions.
http://dx.doi.org/10.1016/j.ijid.2016.02.392
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Background: Coinfection by Dengue and Malaria is not uncom-
mon,though studies are scarce. Both remain among the major
causes of acute febrile illnesses in India. The objective of this
study is to understand and observe the interplay of Dengue and
Malaria,compare their clinical and laboratory features and analyze
the outcomes.
Methods & Materials: A comparative, retrospective study of
Dengue, Malaria and their coinfections was carried out, dur-
ing 2 consecutive monsoons (June-November;2014 and 2015),
in a Mumbai hospital. Febrile patients,during this period,were
investigated forbothDengueandMalaria simultaneously. Elisa(NS-
1/IgM) and peripheral smear examination was done to conﬁrm
Dengue and Malaria respectively. Clinical comparison of signs and
symptoms,severity and outcomes, as per predeﬁned criteria was
systematically carried out.. Relevant laboratory parameters were
compared.
Results: During 2014,of 156 included febrile cases,85(54.48%)
were Dengue monoinfection,55(35.25%) isolated Malaria and
16(10.25%) coinfection cases,whereas in 2015, of 417 febrile
cases,272(65.2%)were Dengue,117(28.05%) isolated Malaria and
28(6.7%) were coinfection cases. The coinfection and Dengue
groups presented with a similar clinical picture. Among compared
laboratory parameters,transaminitis was statistically signiﬁcant
in the coinfection group(p<0.001). Anaemia was signiﬁcant in
the Malaria group,whereas,the Dengue group presented with
raised haematocrit and thrombocytopenia. The coinfection group,
with low haemoglobin and haematocrit, was consistent with
concurrent Malaria coinfection. Among compared severity param-
eters,bleeding manifestations,renal dysfunction and jaundice,
was notable in the coinfection group,compared to the Malaria
group(12% & 3.6% and 6.3% & 3.6% each respectively) with 3
mortalities in the Malaria and 1 in the coinfection group dur-
ing 2014. During 2015,despite increased Dengue and coinfection
cases,numerically, with increased jaundice and bleeding manifes-
tations(16% &8% and 8% & 6% respectively),recovery was total.
Conclusion: Dual infection by Dengue and Malaria was
observed by us, for the ﬁrst time, in 2014. This phenomenon,was
noticed to recur, subsequently,during 2015. as well; and there-
fore merits further studies. Awareness and thus routine testing
for both,helps in effective management and reducing mortality as
observed.
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